Vanguard Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$19B Buy
33,613,298
+13,637
+0% +$7.26M 0.28% 54
2025
Q3
$15B Buy
33,599,661
+263,828
+0.8% +$127M 0.22% 70
2025
Q2
$18.1B Buy
33,335,833
+670,302
+2% +$350M 0.29% 49
2025
Q1
$16.2B Buy
32,665,531
+453,335
+1% +$251M 0.29% 49
2024
Q4
$16.8B Buy
32,212,196
+360,591
+1% +$188M 0.29% 49
2024
Q3
$15.6B Buy
31,851,605
+250,257
+0.8% +$117M 0.28% 53
2024
Q2
$14.1B Buy
31,601,348
+732,728
+2% +$292M 0.27% 55
2024
Q1
$12.3B Buy
30,868,620
+493,126
+2% +$186M 0.24% 63
2023
Q4
$10.2B Buy
30,375,494
+507,267
+2% +$151M 0.22% 75
2023
Q3
$8.73B Buy
29,868,227
+196,316
+0.7% +$61.3M 0.21% 79
2023
Q2
$10.1B Buy
29,671,911
+142,179
+0.5% +$43M 0.24% 68
2023
Q1
$7.54B Buy
29,529,732
+104,546
+0.4% +$25.8M 0.19% 90
2022
Q4
$7.81B Buy
29,425,186
+141,620
+0.5% +$34.5M 0.21% 83
2022
Q3
$5.49B Buy
29,283,566
+282,881
+1% +$60.8M 0.16% 110
2022
Q2
$5.82B Buy
29,000,685
+481,378
+2% +$113M 0.16% 110
2022
Q1
$8.6B Buy
28,519,307
+457,262
+2% +$134M 0.2% 85
2021
Q4
$10.1B Buy
28,062,045
+103,944
+0.4% +$35.8M 0.23% 72
2021
Q3
$9.26B Buy
27,958,101
+349,302
+1% +$117M 0.23% 76
2021
Q2
$8.46B Buy
27,608,799
+182,883
+0.7% +$51.3M 0.21% 80
2021
Q1
$6.76B Buy
27,425,916
+42,243
+0.2% +$10.6M 0.18% 92
2020
Q4
$7.47B Sell
27,383,673
-201,879
-0.7% -$50.1M 0.22% 78
2020
Q3
$6.52B Sell
27,585,552
-288,405
-1% -$64.8M 0.22% 80
2020
Q2
$5.29B Buy
27,873,957
+145,686
+0.5% +$26.1M 0.19% 91
2020
Q1
$4.58B Buy
27,728,271
+703,596
+3% +$129M 0.2% 94
2019
Q4
$5.33B Buy
27,024,675
+295,218
+1% +$55.3M 0.18% 99
2019
Q3
$4.81B Buy
26,729,457
+251,280
+0.9% +$43.5M 0.18% 100
2019
Q2
$4.63B Buy
26,478,177
+508,563
+2% +$87.1M 0.17% 100
2019
Q1
$4.94B Buy
25,969,614
+376,770
+1% +$67M 0.19% 91
2018
Q4
$4.09B Buy
25,592,844
+652,581
+3% +$111M 0.18% 95
2018
Q3
$4.77B Buy
24,940,263
+87,780
+0.4% +$15.6M 0.19% 92
2018
Q2
$3.96B Buy
24,852,483
+503,709
+2% +$76.8M 0.17% 110
2018
Q1
$3.35B Buy
24,348,774
+376,185
+2% +$52.5M 0.15% 124
2017
Q4
$2.92B Buy
23,972,589
+787,833
+3% +$98.6M 0.13% 148
2017
Q3
$2.69B Buy
23,184,756
+468,513
+2% +$51M 0.13% 151
2017
Q2
$2.36B Buy
22,716,243
+181,890
+0.8% +$17.5M 0.12% 175
2017
Q1
$1.92B Buy
22,534,353
+272,754
+1% +$21.5M 0.1% 206
2016
Q4
$1.57B Buy
22,261,599
+576,720
+3% +$42.4M 0.09% 248
2016
Q3
$1.75B Buy
21,684,879
+745,434
+4% +$57.1M 0.1% 205
2016
Q2
$1.54B Buy
20,939,445
+697,689
+3% +$49.1M 0.1% 228
2016
Q1
$1.35B Buy
20,241,756
+553,140
+3% +$34.3M 0.09% 244
2015
Q4
$1.19B Buy
19,688,616
+631,998
+3% +$35.5M 0.08% 267
2015
Q3
$973M Buy
19,056,618
+362,178
+2% +$20.5M 0.07% 303
2015
Q2
$1.01B Buy
18,694,440
+438,372
+2% +$24.5M 0.07% 317
2015
Q1
$1.02B Buy
18,256,068
+842,589
+5% +$47.7M 0.07% 313
2014
Q4
$1.02B Buy
17,413,479
+535,437
+3% +$29.8M 0.07% 294
2014
Q3
$866M Sell
16,878,042
-590,031
-3% -$29.3M 0.07% 313
2014
Q2
$799M Buy
17,468,073
+394,101
+2% +$17.4M 0.06% 346
2014
Q1
$831M Buy
17,073,972
+478,449
+3% +$22.5M 0.07% 307
2013
Q4
$708M Sell
16,595,523
-479,790
-3% -$20.2M 0.06% 343
2013
Q3
$714M Buy
17,075,313
+164,286
+1% +$7.25M 0.07% 307
2013
Q2
$952M Buy
+16,911,027
New +$932M 0.1% 202

Other funds holding ISRG